Have a feature idea you'd love to see implemented?
Let us know!
TIL Instil Bio Inc
Price (delayed)
$24.76
Market cap
$161.58M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$11.57
Enterprise value
$238.5M
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer.
Highlights
TIL's net income has soared by 62% YoY and by 37% QoQ
TIL's EPS has surged by 62% year-on-year and by 37% since the previous quarter
The company's equity fell by 25% YoY and by 10% QoQ
Instil Bio's quick ratio has decreased by 19% QoQ and by 14% YoY
Key stats
What are the main financial stats of TIL
Market
Valuations
Earnings
Shares outstanding
6.53M
Market cap
$161.58M
Enterprise value
$238.5M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.91
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$67.2M
EBITDA
-$63.09M
Free cash flow
-$58.58M
Per share
Balance sheet
Liquidity
EPS
-$11.57
Free cash flow per share
-$9
Book value per share
$27.11
Revenue per share
$0
TBVPS
$41.89
Total assets
$272.56M
Total liabilities
$96.23M
Debt
$83.58M
Equity
$176.33M
Working capital
$122.29M
Debt to equity
0.47
Current ratio
12.9
Quick ratio
11.71
Net debt/EBITDA
-1.22
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-25.1%
Return on equity
-37.4%
Return on invested capital
-18.4%
Return on capital employed
-25.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TIL stock price
How has the Instil Bio stock price performed over time
Intraday
5.99%
1 week
-15.9%
1 month
-29.05%
1 year
238.25%
YTD
224.93%
QTD
-63.22%
Financial performance
How have Instil Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$74.74M
Net income
-$75.17M
Gross margin
N/A
Net margin
N/A
The operating income has soared by 63% YoY and by 37% from the previous quarter
TIL's net income has soared by 62% YoY and by 37% QoQ
Growth
What is Instil Bio's growth rate over time
Valuation
What is Instil Bio stock price valuation
P/E
N/A
P/B
0.91
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
TIL's EPS has surged by 62% year-on-year and by 37% since the previous quarter
The company's equity fell by 25% YoY and by 10% QoQ
TIL's price to book (P/B) is 14% higher than its last 4 quarters average of 0.8
Efficiency
How efficient is Instil Bio business performance
TIL's ROIC has soared by 57% year-on-year and by 37% since the previous quarter
Instil Bio's return on assets has increased by 47% YoY and by 34% QoQ
The return on equity rose by 43% year-on-year and by 33% since the previous quarter
Dividends
What is TIL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TIL.
Financial health
How did Instil Bio financials performed over time
TIL's total assets is 183% greater than its total liabilities
TIL's total assets is down by 20% year-on-year and by 7% since the previous quarter
Instil Bio's quick ratio has decreased by 19% QoQ and by 14% YoY
Instil Bio's debt is 53% less than its equity
The debt to equity has grown by 31% YoY and by 9% from the previous quarter
The company's equity fell by 25% YoY and by 10% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.